SkyePharma buys access to abuse deterrent drug delivery tech
Skyepharma has bought itself access Lucideon’s abuse-deterrent drug delivery technology to use in the development of a new formulation of an undisclosed opioid.
Read More
Tag: iCRT
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
